Covered when ALL of the following supporting documentation is provided for the specific indication
General documentation: Completed prior authorization form with member and provider information, requested drug (Provigil or generic modafinil), dose, quantity/day supply, and diagnosis (ICD-10) codes; submitted via fax or mail per form instructions.
See form completion and submission instructions.
Medication history / Step therapy: Documentation of prior therapeutic failure, intolerance, or contraindication to a generic central nervous system (CNS) stimulant (for example, dextroamphetamine or methylphenidate) when applicable; if requesting more than one 200 mg tablet per day, documentation that 200 mg once daily was inadequate.
Provide prior medication history as requested on the form.
Obstructive sleep apnea specific: Documentation of current receipt and compliance with positive airway pressure (PAP) therapy or documentation of intolerance to PAP, or current use and compliance with a custom titratable oral appliance; include diagnostic polysomnography data (AHI and/or RDI) and relevant symptom checklist items.
Include PSG AHI/RDI and PAP/oral appliance use per form.
Narcolepsy specific: Baseline Epworth Sleepiness Scale (ESS) and Maintenance of Wakefulness Test (MWT) scores; multiple sleep latency test (MSLT) results including mean sleep latency and number of SOREMPs; PSG-reported SOREMPs if available; and cerebrospinal fluid hypocretin-1 level if hypocretin deficiency is suspected.
Provide ESS, MWT, MSLT, PSG, and CSF hypocretin-1 data as applicable.
Idiopathic hypersomnia specific: Baseline ESS and MWT; MSLT results; documentation of presence or absence of cataplexy; and objective documentation of total 24-hour sleep time ≥660 minutes either by polysomnography or by wrist actigraphy averaged across ≥7 days of monitoring.>=660 minutes
PSG or actigraphy demonstrating >=660 minutes (11 hours) total sleep time per 24 hours averaged per monitoring requirements.
Shift-work sleep disorder specific: Symptoms temporally associated with a recurring work schedule that overlaps usual sleep time, accompanied by reduction in total sleep time, symptoms present for ≥3 months, and sleep log or actigraphy monitoring for at least 14 days including both work and free days; exclude sleep disturbance due to another sleep, medical/neurological, mental, medication-related, or substance use disorder.>=3 months; >=14 days monitoring
Provide 14-day sleep log or actigraphy including work and free days and documentation excluding other causes.
Multiple sclerosis related fatigue: Documentation that the member has significant fatigue related to multiple sclerosis and that modafinil is being considered for treatment of this fatigue.
Indicate presence of significant MS-related fatigue on the form.